Custom Allele SupportPeptide-Loaded MonomersBiotinylated FormatsTetramer-Ready Reagents
At Creative Peptides, we provide custom MHC–peptide monomer production services for research teams that need reliable peptide-loaded or peptide-ready MHC reagents for antigen-specific T cell studies, TCR interaction assays, epitope validation, and downstream multimer preparation. Our workflow can be configured around Class I and Class II projects, with support for peptide sequence review, custom peptide synthesis, monomer assembly, purification, biotinylation strategy, and analytical characterization. For programs that also require multimer conversion after monomer generation, our service can align with follow-on custom MHC-peptides tetramer service planning.
MHC–peptide monomers are foundational reagents in immune recognition studies, but many projects stall when the peptide, allele, and final assay format are not considered together from the beginning. A peptide that looks promising in prediction software may load poorly, destabilize the complex, aggregate during handling, or fail to provide a clean monomer for downstream tetramerization or binding analysis.
Practical monomer production support helps solve the issues that commonly slow immunology programs:
We support custom MHC monomer projects for academic groups, biotech teams, CRO workflows, and assay developers that need research-grade reagents built around real experimental requirements. Projects may start from a defined peptide and allele pair, a broader epitope shortlist, or an upstream discovery question supported by resources such as HLA binding peptide screening. Service scope can be tailored for single constructs, comparative panels, or follow-on production of related monomer series.
Every project begins with a technical review of the target MHC class, allele, peptide source, intended assay, and final reagent format. This helps determine whether the project is best approached as a peptide-loaded monomer, a peptide-ready construct, or a comparative development plan.
This front-end review reduces avoidable redesign and aligns the reagent with the customer’s actual research question.
Many MHC monomer projects depend on peptide quality as much as protein quality. We can support the supply of customer-defined epitope peptides through our custom peptide synthesis platform so that sequence identity, purity expectations, and handling recommendations are coordinated with the monomer production plan.
Integrating peptide supply at the start is especially useful when the customer needs one accountable workflow rather than separate peptide and protein vendors.
We produce custom MHC Class I monomers for projects involving defined heavy chain alleles, β2-microglobulin, and target peptide sequences. These monomers can be configured for direct research use or for later multimer preparation depending on project goals.
This service is well suited to antigen-specific CD8-related research workflows, TCR binding studies, and reagent generation for downstream assay development.
Class II monomer projects often require additional attention to peptide design, loading behavior, and final complex stability. We support custom MHC Class II monomer production for teams working with defined alpha/beta chain combinations and research peptides selected for epitope or antigen-presentation studies.
We focus on generating monomers that are practical for CD4-related assay development, binding studies, and controlled comparison across peptide candidates.
Some research programs require one MHC backbone to be evaluated against multiple peptides. For these cases, we can discuss peptide-ready or exchangeable monomer strategies where the project design, allele, and assay purpose support that approach.
These formats can be useful when the goal is flexibility in peptide testing rather than one fixed monomer construct.
Monomer usefulness depends heavily on how well the final material fits the assay. We support project-specific decisions on biotinylation, purification, and analytical release so that the reagent is not only made, but also interpretable in the customer’s workflow.
Customers receive material that is better matched to immobilization studies, assay setup, or later streptavidin-based multimer assembly.
Once a monomer design is established, many groups need follow-on batches for assay expansion, additional peptide comparisons, or repeat studies. We support continuity planning so successful constructs can move beyond a one-off feasibility experiment.
Not every MHC monomer project needs the same reagent design. The table below outlines common custom production formats and the situations in which each format is most useful.
| Monomer Format | Typical Composition | Best Suited For | Typical Deliverables | Key Design Consideration |
|---|---|---|---|---|
| Peptide-Loaded Class I Monomer | Defined Class I heavy chain, β2-microglobulin, and target peptide | TCR interaction studies, antigen-specific T cell workflows, follow-on tetramer preparation | Purified monomer, concentration data, analytical QC package | Peptide stability and allele compatibility strongly affect final complex quality |
| Peptide-Loaded Class II Monomer | Defined Class II alpha/beta chains with selected research peptide | CD4-related assay development, peptide comparison, antigen-presentation studies | Purified monomer, project-specific analytical summary | Peptide design and loading behavior can influence complex stability and interpretability |
| Peptide-Ready Monomer | MHC construct configured for later peptide loading or exchange | Multi-peptide screening, flexible reagent design, staged project workflows | Backbone monomer plus loading or exchange guidance as applicable | Not every allele or study design is equally suitable for exchangeable format selection |
| Biotinylated Monomer | Peptide-loaded monomer prepared with a biotin-compatible downstream format | Tetramer assembly, streptavidin-based capture, surface immobilization studies | Biotinylated monomer with analytical release information | Biotinylation plan should match the final assay architecture and binding readout |
| Non-Biotinylated Monomer | Peptide-loaded monomer prepared without biotin addition | Direct analytical studies, customized follow-on modification strategies, exploratory feasibility work | Purified monomer and core QC data | Best choice when the final attachment or detection strategy has not yet been fixed |
| Comparative Monomer Panel | Multiple monomers built around one allele or one peptide family | Epitope ranking, binder comparison, assay optimization, screening support | Panel set with matched documentation across constructs | Panel design should standardize as many production variables as possible |
Customers often focus first on the peptide sequence, but successful MHC–peptide monomer production depends on several linked inputs. The table below shows which project variables most often affect feasibility, production route, and final reagent performance.
| Project Variable | Why It Matters | Common Project Risk | Service Response | Value to the Customer |
|---|---|---|---|---|
| MHC Class and Allele | Determines structural format, loading strategy, and likely downstream application | Wrong format assumptions can lead to redesign or low-value material | Upfront class/allele review and route planning | Better fit between reagent design and actual experiment |
| Peptide Sequence | Sequence drives loading behavior, solubility, and complex stability | Poorly behaving peptides can delay production or reduce monomer quality | Peptide review plus optional custom peptide synthesis and handling guidance | Cleaner coordination between peptide preparation and monomer assembly |
| Peptide Quality | Impurities or inconsistent peptide handling can compromise complex formation | Incomplete loading or misleading downstream assay results | Peptide acceptance review, storage and solubilization recommendations | More dependable monomer production and comparison across batches |
| Format Choice | Peptide-loaded, peptide-ready, biotinylated, or panel format changes the workflow | A useful monomer for one assay may be poorly suited to another | Format matching based on assay end use and future expansion plans | Less rework when the project evolves into screening or tetramer studies |
| Detection Strategy | Immobilization, tetramerization, or direct interaction studies require different monomer design logic | Assay incompatibility or avoidable reformulation later | Biotinylation and QC plan aligned with the intended readout | Faster transition from reagent delivery to experiment execution |
| Panel Size | Single-construct and multi-construct projects need different production planning | Poor comparability across peptides or alleles | Standardized panel workflows with matched documentation | More interpretable ranking and screening data |
| Follow-On Plans | Some monomers are stepping stones to multimer or broader assay development | Early material may not support later project expansion | Route planning that can connect to custom MHC-peptides tetramer service needs | Better continuity from feasibility study to larger research workflow |
Assay-First Planning
We design the monomer around the actual research use case rather than treating production as an isolated protein task.
Peptide and Monomer Integration
Peptide supply, monomer assembly, and final QC can be coordinated within one workflow to reduce handoff risk.
Class I and II Coverage
We support projects across major monomer formats and adapt the production plan to the structural differences that matter.
Flexible Format Options
Biotinylated, non-biotinylated, peptide-loaded, peptide-ready, and comparative panel formats can be discussed according to project goals.
Practical QC Focus
Analytical work is selected to answer real customer questions about construct quality, comparability, and downstream usability.
Follow-On Workflow Support
Successful monomer projects can be extended into related peptide sets, repeat supply, or downstream multimer preparation.
Our workflow is structured to move from feasibility review to delivery of a research-ready monomer with clear documentation and decision-supportive data.
1
Project Review & Feasibility
2
Peptide Preparation & Input Confirmation
3
Monomer Assembly
4
Purification & Characterization
5
Delivery & Follow-On Planning
Custom monomers are used across immunology, antigen discovery, and assay development workflows where controlled peptide presentation and defined MHC context are essential. Below are representative applications for this service.
Please provide the MHC class, allele, peptide sequence, intended application, preferred format such as biotinylated or non-biotinylated, and target quantity.
Yes. Project planning can be tailored for Class I or Class II formats based on the allele, peptide, and downstream assay.
Yes. Peptide supply can be integrated through custom peptide synthesis so peptide preparation and monomer production are coordinated in one workflow.
No. Biotinylation depends on the intended use. It is often useful for tetramer assembly or capture workflows, but some projects are better served by non-biotinylated monomers.
Yes. Where the allele and study design support it, peptide-ready or exchangeable strategies can be evaluated for screening-oriented projects.
If your team needs custom MHC–peptide monomers for peptide validation, TCR interaction studies, antigen-specific T cell workflows, or tetramer preparation, Creative Peptides can support your project with coordinated peptide supply, monomer production, and assay-oriented quality control. We work with research groups that need practical technical communication, flexible project design, and well-documented reagent delivery. Contact us today to discuss your allele, peptide sequence, monomer format, and study scope.
